Legend Biotech
NASDAQ: LEGNSomerset, US · Founded 2015 · Cayman Islands corporation · 2 known investors
Legend Biotech is a biotechnology company. The provided page content is an external-link disclaimer and contains no substantive information about the company's products or business.
Biotech
Founders & leadership
YX
Yuan Xu, Ph.D.Executive
YH
Ying Huang, Ph.D.Executive
FZ
Fangliang Zhang, Ph.D.Named on SEC filing
YW
Ye Wang, M.S.Named on SEC filing
Investors · 2
Reported raises · per SEC filings
Form D private placements$350.5M disclosed across 2 rounds · 2020–2023
▶$200MraisedApr 2023 · 1 investors · BiotechnologyRule 506(b)
▶$200MraisedApr 2023 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Li Mao, MDDirector
- Tomas HeymanDirector
- Fangliang Zhang, Ph.D.Director
- Darren Xiaohui Ji, M.D., Ph.D.Director
- Li Zhu, Ph.D.Director
- Lori MacomberExecutive Officer
- Patrick Casey, Ph.D.Director
- Ye Wang, M.S.Director
- Philip Wai Man Yau, CPADirector
- Ying Huang, Ph.D.Executive Officer, Director
- Corazon D. Sanders, Ph.D.Director
- Offering amount
- $200M
- Amount sold
- $200M
- First sale
- Apr 2023
- Incorporated
- Corporation, Cayman Islands
- Federal exemptions
- 06b
▶$150.4MraisedApr 2020 · 8 investors · BiotechnologyRule 506(b)
▶$150.4MraisedApr 2020 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Fangliang Zhang, Ph.D.Director
- Yuan Xu, Ph.D.Executive Officer, Director
- Ying Huang, Ph.D.Executive Officer
- Ye Wang, M.S.Director
- Offering amount
- $160.4M
- Amount sold
- $150.4M
- First sale
- Mar 2020
- Incorporated
- Corporation, Cayman Islands, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapJohnson & Johnson168 shared keywordsJohnson & Johnson is a diversified healthcare company operating across 260 subsidiary companies with approximately 138,000 employees globally. The organization develops pharmaceuticals, medical devices, and healthcare solutions across therapeutic areas including cardiology, oncology, immunology, neuroscience, and orthopaedics, alongside digital health and surgical robotics technologies.
Amgen125 shared keywordsAmgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
Companies competing with Legend Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Legend Biotech do?
- Legend Biotech is a biotechnology company. The provided page content is an external-link disclaimer and contains no substantive information about the company's products or business.
- Who are Legend Biotech's investors?
- Legend Biotech's investors include LAV, Lilly Asia Ventures.
- How much funding has Legend Biotech raised?
- Legend Biotech has disclosed $350.5M raised across 2 rounds.
- Where is Legend Biotech headquartered?
- Legend Biotech is headquartered in Somerset, US.